UC Regents issued 2nd CRISPR patent in U.S.

The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier were granted a patent by the U.S. Patent Office covering use of guide RNA formats in CRISPR-Cas9 gene editing technology. The claims cover protein/RNA compositions that can be used to deliver CRISPR-Cas9 into cells as either ribonucleoproteins or DNA-encoded components.